Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Constellation Brands Inc ha un obiettivo di prezzo di consenso pari a $185.62, stabilito in base alle ultime valutazioni degli analisti di 21. Le ultime 3 valutazioni degli analisti sono state rilasciate da Barclays, JP Morgan y Needham il octubre 9, 2025, octubre 8, 2025 y octubre 8, 2025. Con un obiettivo di prezzo medio di $160 tra le Barclays, JP Morgan y Needham, c'è un implicito 13.07% upside per Constellation Brands Inc da queste valutazioni degli analisti.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
10/09/2025 | 3.89% | Barclays | $150 → $147 | Maintains | Equal-Weight | |||
10/08/2025 | 8.13% | JP Morgan | $173 → $153 | Maintains | Neutral | |||
10/08/2025 | 27.21% | Needham | $180 → $180 | Reiterates | Buy → Buy | |||
10/07/2025 | 13.07% | Morgan Stanley | $176 → $160 | Maintains | Equal-Weight | |||
10/03/2025 | 23.67% | UBS | $205 → $175 | Maintains | Buy | |||
10/02/2025 | 18.73% | Goldman Sachs | $196 → $168 | Maintains | Buy | |||
09/25/2025 | 9.54% | Wells Fargo | $170 → $155 | Maintains | Overweight | |||
09/23/2025 | 2.47% | Citigroup | $155 → $145 | Maintains | Neutral | |||
09/12/2025 | 6.01% | Barclays | $202 → $150 | Downgrade | Overweight → Equal-Weight | |||
09/04/2025 | 37.81% | Bernstein | $225 → $195 | Maintains | Outperform | |||
09/04/2025 | 9.54% | Citigroup | $174 → $155 | Maintains | Neutral | |||
09/04/2025 | 34.28% | BMO Capital | $215 → $190 | Maintains | Outperform | |||
09/04/2025 | 7.42% | TD Cowen | $180 → $152 | Maintains | Hold | |||
09/03/2025 | 11.66% | Deutsche Bank | $182 → $158 | Maintains | Hold | |||
09/03/2025 | 47.7% | Roth Capital | $239 → $209 | Reiterates | Buy → Buy | |||
09/03/2025 | 24.38% | Morgan Stanley | $195 → $176 | Maintains | Equal-Weight | |||
09/03/2025 | 0.35% | B of A Securities | $150 → $142 | Maintains | Underperform | |||
09/03/2025 | 38.52% | Goldman Sachs | $225 → $196 | Maintains | Buy | |||
09/03/2025 | 27.21% | Needham | $200 → $180 | Maintains | Buy | |||
09/03/2025 | 20.14% | Wells Fargo | $196 → $170 | Maintains | Overweight | |||
09/03/2025 | 26.5% | Jefferies | $205 → $179 | Maintains | Buy | |||
07/07/2025 | 44.88% | Jefferies | $194 → $205 | Upgrade | Hold → Buy | |||
07/03/2025 | 44.88% | UBS | $195 → $205 | Maintains | Buy | |||
07/03/2025 | 22.97% | Citigroup | $170 → $174 | Maintains | Neutral | |||
07/03/2025 | 28.62% | B of A Securities | $180 → $182 | Maintains | Neutral | |||
07/03/2025 | 28.62% | JP Morgan | $170 → $182 | Maintains | Neutral | |||
07/03/2025 | 41.34% | Needham | $195 → $200 | Maintains | Buy | |||
06/26/2025 | 42.76% | Barclays | $207 → $202 | Maintains | Overweight | |||
06/26/2025 | 20.14% | JP Morgan | $194 → $170 | Maintains | Neutral | |||
06/25/2025 | 37.81% | UBS | $205 → $195 | Maintains | Buy | |||
06/25/2025 | 38.52% | Wells Fargo | $210 → $196 | Maintains | Overweight | |||
06/25/2025 | 37.81% | Needham | $215 → $195 | Maintains | Buy | |||
06/18/2025 | 27.21% | B of A Securities | $195 → $180 | Maintains | Neutral | |||
06/18/2025 | 20.14% | Citigroup | $190 → $170 | Maintains | Neutral | |||
04/14/2025 | 64.66% | RBC Capital | $289 → $233 | Maintains | Outperform | |||
04/14/2025 | 46.29% | Barclays | $203 → $207 | Maintains | Overweight | |||
04/11/2025 | 34.28% | Citigroup | $200 → $190 | Maintains | Neutral | |||
04/11/2025 | 59.01% | Goldman Sachs | $260 → $225 | Maintains | Buy | |||
04/11/2025 | 37.1% | JP Morgan | $203 → $194 | Maintains | Neutral | |||
04/11/2025 | 51.94% | BMO Capital | $260 → $215 | Maintains | Outperform | |||
04/11/2025 | 37.81% | Morgan Stanley | $202 → $195 | Maintains | Equal-Weight | |||
04/11/2025 | 51.94% | Needham | $215 → $215 | Reiterates | Buy → Buy | |||
04/10/2025 | 51.94% | Needham | $215 → $215 | Reiterates | Buy → Buy | |||
04/03/2025 | 80.92% | Roth MKM | $284 → $256 | Maintains | Buy | |||
04/02/2025 | 48.41% | Wells Fargo | $230 → $210 | Maintains | Overweight | |||
03/27/2025 | 43.46% | Barclays | $205 → $203 | Maintains | Overweight | |||
03/27/2025 | 51.94% | Needham | $240 → $215 | Maintains | Buy | |||
03/20/2025 | 41.34% | Citigroup | $260 → $200 | Downgrade | Buy → Neutral | |||
03/13/2025 | 44.88% | Barclays | $214 → $205 | Maintains | Overweight | |||
03/07/2025 | 104.24% | RBC Capital | $293 → $289 | Maintains | Outperform | |||
02/27/2025 | 42.76% | Morgan Stanley | $220 → $202 | Downgrade | Overweight → Equal-Weight | |||
02/03/2025 | 107.07% | RBC Capital | $293 → $293 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 41.34% | Piper Sandler | $245 → $200 | Downgrade | Overweight → Neutral | |||
01/27/2025 | 69.61% | Needham | $240 → $240 | Maintains | Buy | |||
01/14/2025 | 34.28% | Truist Securities | $255 → $190 | Maintains | Hold | |||
01/14/2025 | 51.24% | Barclays | $282 → $214 | Maintains | Overweight | |||
01/13/2025 | 107.07% | RBC Capital | $308 → $293 | Maintains | Outperform | |||
01/13/2025 | 76.68% | Evercore ISI Group | $300 → $250 | Maintains | Outperform | |||
01/13/2025 | 73.14% | Piper Sandler | $300 → $245 | Maintains | Overweight | |||
01/13/2025 | 55.48% | Morgan Stanley | $280 → $220 | Maintains | Overweight | |||
01/13/2025 | 69.61% | Needham | $280 → $240 | Reiterates | Buy → Buy | |||
01/13/2025 | 43.46% | JP Morgan | $262 → $203 | Downgrade | Overweight → Neutral | |||
01/13/2025 | 42.05% | Jefferies | $310 → $201 | Downgrade | Buy → Hold | |||
01/10/2025 | 97.88% | Needham | $280 → $280 | Reiterates | Buy → Buy | |||
01/08/2025 | 83.75% | TD Cowen | $270 → $260 | Maintains | Hold | |||
01/08/2025 | 99.29% | Barclays | $300 → $282 | Maintains | Overweight | |||
01/07/2025 | 85.16% | JP Morgan | $293 → $262 | Maintains | Overweight | |||
01/07/2025 | 117.67% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
01/07/2025 | 94.35% | Wells Fargo | $295 → $275 | Maintains | Overweight | |||
12/20/2024 | 97.88% | Needham | $280 → $280 | Reiterates | Buy → Buy | |||
12/06/2024 | 97.88% | Needham | → $280 | Initiates | → Buy | |||
11/26/2024 | 108.48% | Wells Fargo | $300 → $295 | Maintains | Overweight | |||
11/25/2024 | 84.45% | Exane BNP Paribas | → $261 | Initiates | → Neutral | |||
11/19/2024 | 117.67% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
10/15/2024 | 115.55% | BMO Capital | $315 → $305 | Maintains | Outperform | |||
10/08/2024 | 90.81% | TD Cowen | $300 → $270 | Downgrade | Buy → Hold | |||
10/07/2024 | 112.01% | Barclays | $309 → $300 | Maintains | Overweight | |||
10/07/2024 | 80.21% | B of A Securities | $300 → $255 | Downgrade | Buy → Neutral | |||
10/04/2024 | 107.07% | JP Morgan | $307 → $293 | Maintains | Overweight | |||
10/04/2024 | 80.21% | Truist Securities | $265 → $255 | Maintains | Hold | |||
10/04/2024 | 110.6% | Roth MKM | $298 → $298 | Reiterates | Buy → Buy | |||
10/04/2024 | 112.01% | Evercore ISI Group | $310 → $300 | Maintains | Outperform | |||
10/04/2024 | 117.67% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
09/24/2024 | 118.37% | Barclays | $295 → $309 | Maintains | Overweight | |||
09/17/2024 | 117.67% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
09/09/2024 | 108.48% | UBS | $320 → $295 | Maintains | Buy | |||
09/04/2024 | 119.08% | Jefferies | $311 → $310 | Maintains | Buy | |||
09/04/2024 | 110.6% | Roth MKM | $303 → $298 | Maintains | Buy | |||
09/03/2024 | 116.96% | JP Morgan | $320 → $307 | Maintains | Overweight | |||
09/03/2024 | 117.67% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
08/26/2024 | 97.88% | Morgan Stanley | $305 → $280 | Maintains | Overweight | |||
07/31/2024 | 117.67% | RBC Capital | $308 → $308 | Reiterates | Outperform → Outperform | |||
07/19/2024 | 108.48% | Barclays | $287 → $295 | Maintains | Overweight | |||
07/05/2024 | 126.15% | UBS | $315 → $320 | Maintains | Buy | |||
07/05/2024 | 119.79% | Jefferies | $310 → $311 | Maintains | Buy | |||
07/05/2024 | 126.15% | JP Morgan | $291 → $320 | Maintains | Overweight | |||
07/05/2024 | 114.13% | Roth MKM | $305 → $303 | Maintains | Buy | |||
07/05/2024 | 122.61% | BMO Capital | $315 → $315 | Maintains | Outperform | |||
07/03/2024 | 87.28% | Truist Securities | $265 → $265 | Maintains | Hold | |||
06/20/2024 | 122.61% | UBS | $320 → $315 | Maintains | Buy |
El último precio objetivo de Constellation Brands (NYSE:STZ) fue comunicado por Barclays el octubre 9, 2025. La firma de analistas fijó un precio objetivo para $147.00 que espera STZ a rise dentro de 12 meses (un posible 3.89% upside). 74 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Constellation Brands (NYSE:STZ) fue proporcionada por Barclays, y Constellation Brands mantuvo su equal-weight calificación.
La última revisión al alza de Constellation Brands Inc se produjo en julio 7, 2025, cuando Jefferies elevó su precio objetivo a $205. Jefferies anteriormente tenía a hold para Constellation Brands Inc.
La última revisión a la baja de Constellation Brands Inc se produjo en septiembre 12, 2025, cuando Barclays cambió su precio objetivo de $202 a $150 para Constellation Brands Inc.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Constellation Brands, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Constellation Brands se registró el octubre 9, 2025, por lo que la próxima calificación estará disponible en torno al octubre 9, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Constellation Brands (STZ) fue un mantuvo con un precio objetivo de $150.00 a $147.00. El precio actual al que cotiza Constellation Brands (STZ) es de $141.50, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.